Safe Drugs Act & State Bills Threaten Compounded GLP-1 Access
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
Safe Drugs Act & State Bills Threaten Compounded GLP-1 Access
-
ナレーター：
-
著者：
Here’s a clean, professional Show Notes section you can use:
Show Notes
In this episode, I’m joined by Sabina Hemmi, founder of GLP Winner, to break down the growing wave of federal and state legislation targeting compounded GLP-1 medications.
We discuss:
Why transparent GLP-1 pricing matters
How GLP Winner helps patients compare clinics without deceptive funnels
The federal Safe Drugs Act and emerging state bills
How some legislation could impact all compounding, not just GLP-1s
What this means for hospice care, pediatrics, veterinary medicine, and more
Why patient advocacy at the state level matters right now
The real-life side effects and lived experience behind the policy debate
If you live in a state where legislation is moving, contact your representative and share your story. Patient voices are making a difference.
Connect with Sabina
TikTok: https://www.tiktok.com/@lawliepopInstagram: https://www.instagram.com/lawliepops/YouTube: https://www.youtube.com/@lawliepopX/Twitter: https://x.com/lawliepopSubstack: https://substack.com/@lawliepopLinkedIn: https://www.linkedin.com/in/sabina-hemmi/
Resources
Visit GLP-1 Studio for the latest bill updates and advocacy tools.
Get full access to GLP-1 Studio at glp1studio.substack.com/subscribe